{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:04:02Z","timestamp":1773140642071,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K09820"],"award-info":[{"award-number":["16K09820"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health and Labor Sciences Research Grant","award":["201911070A"],"award-info":[{"award-number":["201911070A"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Autoimmune coagulation factor XIII deficiency is a bleeding disorder caused by the formation of autoantibodies against the coagulation factor XIII (FXIII); however, the molecular mechanism underlying this process is unknown. Therefore, in the present study, we aimed to elucidate this mechanism by performing whole-exome sequencing analysis of 20 cases of autoimmune FXIII deficiency. We identified approximately 21,788\u201323,916 variants in each case. In addition to their ability to activate T cells, present antigens, and immune tolerance, the candidate alleles were further narrowed down according to their allelic frequencies and the magnitude of damage caused by the substitution of amino acids. After selecting 44 candidate alleles, we investigated whether they were associated with the FXIII inhibitory titers and\/or the anti-FXIII autoantibodies. We found that two polymorphisms whose variant allele frequencies were significantly lower in the patients tended to decrease FXIII inhibitory titers as the number of variant alleles increased. We also found that five polymorphisms whose variant allele frequencies were significantly higher in the patients tended to increase the levels of the anti-FXIII autoantibodies as the number of variant alleles increased. All of these polymorphisms were found in the human leukocyte antigen (HLA) class I and II molecules and their associated genes. In particular, the HLA class II molecule and its associated genes were found to be involved in the presentation of foreign antigens as well as the negative regulation of the proliferation of T-cells and the release of cytokines. Polymorphisms in the HLA class II molecules and the cytotoxic T lymphocyte antigen 4 have been reported to be associated with the development of autoantibodies in acquired hemophilia A. Therefore, we hypothesized that these polymorphisms may be associated with the development of autoantibodies in autoimmune FXIII deficiency.<\/jats:p>","DOI":"10.1371\/journal.pone.0257322","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T17:39:52Z","timestamp":1631295592000},"page":"e0257322","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9487-3253","authenticated-orcid":true,"given":"Tsukasa","family":"Osaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"issue":"1","key":"pone.0257322.ref001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1538-7836.2010.04070.x","article-title":"Factor XIII: novel structural and functional aspects","volume":"9","author":"I Kom\u00e1romi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"4","key":"pone.0257322.ref002","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12185-012-1064-3","article-title":"Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control","volume":"95","author":"A. Ichinose","year":"2012","journal-title":"Int J Hematol"},{"issue":"1","key":"pone.0257322.ref003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.08.002","article-title":"Autoimmune acquired factor XIII deficiency due to anti-factor XIII\/13 antibodies: A summary of 93 patients","volume":"31","author":"Ichinose A; Japanese Collaborative Research Group on AH13","year":"2017","journal-title":"Blood Rev"},{"issue":"4","key":"pone.0257322.ref004","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1160\/TH-16-05-0362","article-title":"Philippou H; Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Recommendation for ISTH\/SSC Criterion 2015 for autoimmune acquired factor XIII\/13 deficiency","volume":"116","author":"A Ichinose","year":"2016","journal-title":"Thromb Haemost"},{"issue":"6","key":"pone.0257322.ref005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","article-title":"Acquired factor XIII deficiency: A review","volume":"57","author":"MTS Yan","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"pone.0257322.ref006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijlh.12756","article-title":"Factor XIII deficiency diagnosis: Challenges and tools","volume":"40","author":"M Karimi","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"pone.0257322.ref007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.blre.2016.06.002","article-title":"Blood coagulation factor XIII and factor XIII deficiency","volume":"30","author":"A Dorgalaleh","year":"2016","journal-title":"Blood Rev"},{"issue":"1","key":"pone.0257322.ref008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11239-012-0818-3","article-title":"Acquired FXIII inhibitors: a systematic review","volume":"36","author":"M Franchini","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"Suppl 3","key":"pone.0257322.ref009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02259.x","article-title":"Genetic markers in acquired haemophilia","volume":"16","author":"J Oldenburg","year":"2010","journal-title":"Haemophilia"},{"issue":"102","key":"pone.0257322.ref010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2516.2008.01976.x","article-title":"HLA genotype in patients with acquired haemophilia A","volume":"16","author":"A Pavlova","year":"2010","journal-title":"Haemophilia"},{"issue":"2","key":"pone.0257322.ref011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2516.2007.01618.x","article-title":"Increased frequency of the CTLA-4 49 A\/G polymorphism in patients with acquired haemophilia A compared to healthy controls","volume":"14","author":"A Pavlova","year":"2008","journal-title":"Haemophilia"},{"issue":"1","key":"pone.0257322.ref012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2011.08890.x","article-title":"Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?","volume":"156","author":"A Mahendra","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0257322.ref013","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5045\/kjh.2011.46.1.49","article-title":"Identification of a shared F8 mutation in the Korean patients with acquired hemophilia A","volume":"46","author":"SH Hwang","year":"2011","journal-title":"Korean J Hematol"},{"issue":"23","key":"pone.0257322.ref014","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2015-12-685735","article-title":"Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients","volume":"127","author":"MM Gorski","year":"2016","journal-title":"Blood"},{"issue":"6","key":"pone.0257322.ref015","doi-asserted-by":"crossref","first-page":"e0218258","DOI":"10.1371\/journal.pone.0218258","article-title":"ABIRISK consortium. Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A","volume":"14","author":"D Bachelet","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"pone.0257322.ref016","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A","volume":"7","author":"A Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"5","key":"pone.0257322.ref017","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/jth.12877","article-title":"autoantibodies block FXIII-A2 B2 assembly and steal FXIII-A from native FXIII-A2 B2","volume":"13","author":"M Souri","year":"2015","journal-title":"J Thromb Haemost"},{"key":"pone.0257322.ref018","volume-title":"Molecular cloning: a laboratory manual","author":"JE Sambrook","year":"1989"},{"key":"pone.0257322.ref019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.fsigen.2014.08.013","article-title":"A SNaPshot of next generation sequencing for forensic SNP analysis","volume":"14","author":"R Daniel","year":"2015","journal-title":"Forensic Sci Int Genet"},{"issue":"6","key":"pone.0257322.ref020","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1160\/TH14-09-0745","article-title":"Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90% of cases with autoimmune haemorrhaphilia XIII\/13","volume":"113","author":"T Osaki","year":"2015","journal-title":"Thromb Haemost"},{"issue":"7253","key":"pone.0257322.ref021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.321.7253.93","article-title":"Science, medicine, and the future: Tolerance and autoimmunity","volume":"321","author":"IR Mackay","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"pone.0257322.ref022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.molmed.2005.12.005","article-title":"Genetic progress towards the molecular basis of autoimmunity","volume":"12","author":"SH Pearce","year":"2006","journal-title":"Trends Mol Med"},{"issue":"15","key":"pone.0257322.ref023","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.91.15.7296","article-title":"Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII","volume":"91","author":"VC Yee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6939","key":"pone.0257322.ref024","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"H Ueda","year":"2003","journal-title":"Nature"},{"issue":"12","key":"pone.0257322.ref025","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.4049\/jimmunol.176.12.7354","article-title":"BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation","volume":"176","author":"T Nguyen","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"pone.0257322.ref026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2004-04-1596","article-title":"The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation","volume":"105","author":"JL Riley","year":"2005","journal-title":"Blood"},{"issue":"5","key":"pone.0257322.ref027","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1074-7613(04)00116-5","article-title":"The roles of the new negative T cell costimulatory pathways in regulating autoimmunity","volume":"20","author":"SJ Khoury","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"pone.0257322.ref028","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/444435","article-title":"The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites","volume":"77","author":"BA Rybicki","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"4","key":"pone.0257322.ref029","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"R Valentonyte","year":"2005","journal-title":"Nat Genet"},{"issue":"5","key":"pone.0257322.ref030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0039.2004.00310.x","article-title":"Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3","volume":"64","author":"P Price","year":"2004","journal-title":"Tissue Antigens"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T17:40:38Z","timestamp":1631295638000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257322"}},"subtitle":[],"editor":[{"given":"Arijit","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0257322","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}